CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 


Regenxbio Inc.  (RGNX)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
   Industry Biotechnology & Drugs
   Sector  Healthcare

Regenxbio's Quick Ratio

RGNX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth



Select the Comparisons : Select the Ratio:                        

RGNX Quick Ratio (Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
(Sep 30 2017)
III. Quarter
(Jun 30 2017)
II. Quarter
(Mar 31 2017)
I. Quarter
Y / Y Current Liabilities Change 21.26 % 213.16 % -51.75 % 90.17 % 259.67 %
Y / Y Cash & cash equivalent Change 57.65 % 79.53 % 81.61 % 72.05 % 44.29 %
Quick Ratio MRQ 45.91 33.27 64.25 41.05 35.31
Overall Ranking # 80 # 101 # 54 # 79 # 81
Seq. Current Liabilities Change 3.62 % 86.28 % -34.3 % -4.38 % 167.6 %
Seq. Cash & cash equivalent Change 42.97 % -3.53 % 2.83 % 11.16 % 62.82 %



Quick Ratio first quarter 2018 Comment
Regenxbio's Cash & cash equivalent grew by 42.97 % in I. Quarter sequntially, faster than Current Liabilities, this led to improvement in Regenxbio's Quick Ratio to 45.91, Quick Ratio remained below Regenxbio Inc. average.

Within Biotechnology & Drugs industry 4 other companies have achieved higher Quick Ratio than Regenxbio in first quarter 2018. While Quick Ratio total ranking has improved so far to 80, from total ranking in previous quarter at 101.

Explain Quick Ratio?
What are RGNX Segments?
See Quick Ratio RGNX on the trailing twelve month basis
Quick Ratio first quarter 2018 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 5
Healthcare Sector # 7
Overall Market # 80


Quick Ratio Statistics
High Average Low
100.04 51.69 17.07
(Dec 31 2015)   (Sep 30 2016)


You need to upgrade your Flash Player


Financial Statements
Regenxbio's Current Liabilities $ 5 Millions Visit RGNX's Balance sheet
Regenxbio's Cash & cash equivalent $ 230 Millions Visit RGNX's Balance sheet
Source of RGNX's Sales Visit RGNX's Sales by Geography




Companies with similar Quick Ratio in the quarter endingMar 31 2018, within Biotechnology & Drugs Industry Quick RatioMar 31 2018 MRQ Cash & cash equivalentMar 31 2018 MRQ Current Liabilities
Adverum Biotechnologies, Inc.  119.40 $ 247.037  Millions$ 2.069  Millions
Krystal Biotech, Inc.  104.49 $ 47.228  Millions$ 0.452  Millions
Neuralstem, Inc.  89.00 $ 9.724  Millions$ 0.109  Millions
Catalyst Biosciences, Inc.  49.49 $ 143.518  Millions$ 2.900  Millions
Regenxbio Inc.  45.91 $ 229.867  Millions$ 5.007  Millions
Renovacare, Inc.  27.96 $ 2.385  Millions$ 0.085  Millions
Atara Biotherapeutics, Inc.  27.70 $ 407.515  Millions$ 14.713  Millions
Casi Pharmaceuticals, Inc.  25.05 $ 51.210  Millions$ 2.044  Millions
Protokinetix, Inc.  24.85 $ 0.192  Millions$ 0.008  Millions
Genocea Biosciences, Inc.  24.44 $ 51.179  Millions$ 2.094  Millions
Crispr Therapeutics Ag  23.74 $ 341.767  Millions$ 14.395  Millions
Fennec Pharmaceuticals Inc.  22.78 $ 26.719  Millions$ 1.173  Millions
Acceleron Pharma Inc  22.55 $ 291.855  Millions$ 12.942  Millions
Voyager Therapeutics, Inc.  20.35 $ 218.198  Millions$ 10.723  Millions
Microbot Medical Inc.  20.27 $ 9.487  Millions$ 0.468  Millions
Audentes Therapeutics, Inc.  20.24 $ 326.218  Millions$ 16.119  Millions
Iovance Biotherapeutics, Inc.  20.22 $ 297.082  Millions$ 14.690  Millions
Dare Bioscience, Inc.  19.35 $ 15.625  Millions$ 0.808  Millions
Novus Therapeutics, Inc.  18.91 $ 22.523  Millions$ 1.191  Millions
Gtx Inc  18.48 $ 32.144  Millions$ 1.739  Millions
Vical Inc  17.78 $ 56.116  Millions$ 3.156  Millions
G1 Therapeutics, Inc.  15.54 $ 194.387  Millions$ 12.507  Millions
Enzon Pharmaceuticals, Inc.  15.47 $ 7.240  Millions$ 0.468  Millions
Pulse Biosciences, Inc.  15.23 $ 33.375  Millions$ 2.191  Millions
Aclaris Therapeutics, Inc.  13.53 $ 186.977  Millions$ 13.823  Millions
Aerie Pharmaceuticals Inc  13.29 $ 333.977  Millions$ 25.136  Millions
Alder Biopharmaceuticals Inc  12.92 $ 330.961  Millions$ 25.611  Millions
Intellia Therapeutics, Inc.  12.81 $ 327.778  Millions$ 25.583  Millions
Momenta Pharmaceuticals Inc  12.17 $ 323.900  Millions$ 26.624  Millions
Allena Pharmaceuticals, Inc.  11.92 $ 86.382  Millions$ 7.246  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CPST's Profile

Stock Price

CPST's Financials

Business Description

Fundamentals

Charts & Quotes

CPST's News

Suppliers

CPST's Competitors

Customers & Markets

Economic Indicators

CPST's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071